ALB and cancer: Given the inhibitory effect of US‐triggered NO‐releasing nanoparticles on platelets at tumor sites, this study also assessed the impact of SNO‐HSA‐PTX + US on the normal hemostatic function of platelets, and the results reveled that SNO‐HSA‐PTX+US treatment did not significantly influence the bleeding time in mice, underscoring the safety of SNO‐HSA‐PTX for in vivo cancer treatment.[60]